{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:26:57Z","timestamp":1778801217330,"version":"3.51.4"},"reference-count":13,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.1248\/bpb.b21-00520","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T22:15:52Z","timestamp":1633040152000},"page":"1399-1402","source":"Crossref","is-referenced-by-count":13,"title":["Accumulation of Toxic Advanced Glycation End-Products Induces Cytotoxicity and Inflammation in Hepatocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells"],"prefix":"10.1248","volume":"44","author":[{"given":"Chigusa","family":"Kikuchi","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University"},{"name":"Educational Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Nagoya City University"},{"name":"Laboratory of Community Medicine, Showa Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Sakasai-Sakai","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Okimura","sequence":"additional","affiliation":[{"name":"Educational Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Nagoya City University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinako","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Educational Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Nagoya City University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Takata","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamihide","family":"Matsunaga","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University"},{"name":"Educational Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Nagoya City University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Takahashi Y, Fukusato T. Histopathology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. <i>World J. Gastroenterol.<\/i>, <b>20<\/b>, 15539\u201315548 (2014).","DOI":"10.3748\/wjg.v20.i42.15539"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Povsic M, Wong OY, Perry R, Bottomley J. A structured literature review of the epidemiology and disease burden of non-alcoholic steatohepatitis (NASH). <i>Adv. Ther.<\/i>, <b>36<\/b>, 1574\u20131594 (2019).","DOI":"10.1007\/s12325-019-00960-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Rungratanawanich W, Qu Y, Wang X, Essa MM, Song BJ. Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury. <i>Exp. Mol. Med.<\/i>, <b>53<\/b>, 168\u2013188 (2021).","DOI":"10.1038\/s12276-021-00561-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Sakasai-Sakai A, Takata T, Takino J, Takeuchi M. The relevance of toxic AGEs (TAGE) cytotoxicity to NASH pathogenesis: a mini-review. <i>Nutrients<\/i>, <b>11<\/b>, 462 (2019).","DOI":"10.3390\/nu11020462"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Chavez-Tapia NC, Rosso N, Tiribelli C. <i>In vitro<\/i> models for the study of non-alcoholic fatty liver disease. <i>Curr. Med. Chem.<\/i>, <b>18<\/b>, 1079\u20131084 (2011).","DOI":"10.2174\/092986711794940842"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Takino J, Kobayashi Y, Takeuchi M. The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity. <i>J. Gastroenterol.<\/i>, <b>45<\/b>, 646\u2013655 (2010).","DOI":"10.1007\/s00535-009-0193-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Sakasai-Sakai A, Takata T, Takino J, Takeuchi M. Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death. <i>Sci. Rep.<\/i>, <b>7<\/b>, 14282 (2017).","DOI":"10.1038\/s41598-017-14711-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Sakasai-Sakai A, Takata T, Takeuchi M. Intracellular toxic advanced glycation end-products promote the production of reactive oxygen species in HepG2 cells. <i>Int. J. Mol. Sci.<\/i>, <b>21<\/b>, 4861 (2020).","DOI":"10.3390\/ijms21144861"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Iwao T, Toyota M, Miyagawa Y, Okita H, Kiyokawa N, Akutsu H, Umezawa A, Nagata K, Matsunaga T. Differentiation of human induced pluripotent stem cells into functional enterocyte-like cells using a simple method. <i>Drug Metab. Pharmacokinet.<\/i>, <b>29<\/b>, 44\u201351 (2014).","DOI":"10.2133\/dmpk.DMPK-13-RG-005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kondo Y, Iwao T, Yoshihashi S, Mimori K, Ogihara R, Nagata K, Kurose K, Saito M, Niwa T, Suzuki T, Miyata N, Ohmori S, Nakamura K, Matsunaga T. Histone deacetylase inhibitor valproic acid promotes the differentiation of human induced pluripotent stem cells into hepatocyte-like cells. <i>PLOS ONE<\/i>, <b>9<\/b>, e104010 (2014).","DOI":"10.1371\/journal.pone.0104010"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Takata T, Sakasai-Sakai A, Takino J, Takeuchi M. Evidence for toxic advanced glycation end-products generated in the normal rat liver. <i>Nutrients<\/i>, <b>11<\/b>, 1612 (2019).","DOI":"10.3390\/nu11071612"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Takino J, Nagamine K, Takeuchi M, Hori T. <i>In vitro<\/i> identification of nonalcoholic fatty liver disease-related protein hnRNPM. <i>World J. Gastroenterol.<\/i>, <b>21<\/b>, 1784\u20131793 (2015).","DOI":"10.3748\/wjg.v21.i6.1784"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Braunersreuther V, Viviani GL, Mach F, Montecucco F. Role of cytokines and chemokines in non-alcoholic fatty liver disease. <i>World J. Gastroenterol.<\/i>, <b>18<\/b>, 727\u2013735 (2012).","DOI":"10.3748\/wjg.v18.i8.727"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/10\/44_b21-00520\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:38:09Z","timestamp":1715143089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/10\/44_b21-00520\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b21-00520","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"article-number":"b21-00520"}}